Plasma polyunsaturated fatty acids and mental disorders in adolescence and early adulthood: cross-sectional and longitudinal associations in a general population cohort
- PMID: 34059620
- PMCID: PMC8167090
- DOI: 10.1038/s41398-021-01425-4
Plasma polyunsaturated fatty acids and mental disorders in adolescence and early adulthood: cross-sectional and longitudinal associations in a general population cohort
Abstract
Polyunsaturated fatty acids (PUFAs) may be pertinent to the development of mental disorders, for example via modulation of inflammation and synaptogenesis. We wished to examine cross-sectional and longitudinal associations between PUFAs and mental disorders in a large cohort of young people. Participants in the Avon Longitudinal Study of Parents and Children were interviewed and provided blood samples at two sampling periods when approximately 17 and 24 years old. Plasma PUFA measures (total omega-6 [n-6], total omega-3 [n-3], n-6:n-3 ratio and docosahexaenoic acid [DHA] percentage of total fatty acids) were assessed using nuclear magnetic resonance spectroscopy. Cross-sectional and longitudinal associations between standardised PUFA measures and three mental disorders (psychotic disorder, moderate/severe depressive disorder and generalised anxiety disorder [GAD]) were measured by logistic regression, adjusting for age, sex, body mass index and cigarette smoking. There was little evidence of cross-sectional associations between PUFA measures and mental disorders at age 17. At age 24, the n-6:n-3 ratio was positively associated with psychotic disorder, depressive disorder and GAD, while DHA was inversely associated with psychotic disorder. In longitudinal analyses, there was evidence of an inverse association between DHA at age 17 and incident psychotic disorder at age 24 (adjusted odds ratio 0.44, 95% confidence interval 0.22-0.87) with little such evidence for depressive disorder or GAD. There was little evidence for associations between change in PUFA measures from 17 to 24 years and incident mental disorders at 24 years. These findings provide support for associations between PUFAs and mental disorders in early adulthood, and in particular, for DHA in adolescence in relation to prevention of psychosis.
Conflict of interest statement
D.M., M.C. and D.R.C. report a patent-pending (UK Patent Application No. 1919155.0, “Biomarkers to predict psychosis”). C.H., H.J.H. and S.Z. report no financial relationships with commercial interests.
Figures

Similar articles
-
Longitudinal Trajectories of Plasma Polyunsaturated Fatty Acids and Associations With Psychosis Spectrum Outcomes in Early Adulthood.Biol Psychiatry. 2024 Nov 15;96(10):772-781. doi: 10.1016/j.biopsych.2024.04.004. Epub 2024 Apr 15. Biol Psychiatry. 2024. PMID: 38631425
-
Plasma Polyunsaturated Fatty Acid Levels and Mental Health in Middle-Aged and Elderly Adults.Nutrients. 2024 Nov 26;16(23):4065. doi: 10.3390/nu16234065. Nutrients. 2024. PMID: 39683459 Free PMC article.
-
Sex differences in the association between plasma polyunsaturated fatty acids levels and moderate-to-severe plaque psoriasis severity: a cross-sectional and longitudinal study.J Transl Med. 2023 Nov 20;21(1):834. doi: 10.1186/s12967-023-04726-y. J Transl Med. 2023. PMID: 37986112 Free PMC article.
-
Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms.Lipids Health Dis. 2020 Jul 3;19(1):159. doi: 10.1186/s12944-020-01337-0. Lipids Health Dis. 2020. PMID: 32620164 Free PMC article. Review.
-
Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?Lipids Health Dis. 2007 Sep 18;6:21. doi: 10.1186/1476-511X-6-21. Lipids Health Dis. 2007. PMID: 17877810 Free PMC article. Review.
Cited by
-
Omega-3 fatty acids and major depression: a Mendelian randomization study.Transl Psychiatry. 2024 May 29;14(1):222. doi: 10.1038/s41398-024-02932-w. Transl Psychiatry. 2024. PMID: 38811538 Free PMC article.
-
Association of depression with severe non-alcoholic fatty liver disease: evidence from the UK Biobank study and Mendelian randomization analysis.Sci Rep. 2024 Nov 19;14(1):28561. doi: 10.1038/s41598-024-79100-z. Sci Rep. 2024. PMID: 39557910 Free PMC article.
-
A Preliminary Comparison of Plasma Tryptophan Metabolites and Medium- and Long-Chain Fatty Acids in Adult Patients with Major Depressive Disorder and Schizophrenia.Medicina (Kaunas). 2023 Feb 20;59(2):413. doi: 10.3390/medicina59020413. Medicina (Kaunas). 2023. PMID: 36837614 Free PMC article.
-
Prognostic models predicting transition to psychotic disorder using blood-based biomarkers: a systematic review and critical appraisal.Transl Psychiatry. 2023 Oct 28;13(1):333. doi: 10.1038/s41398-023-02623-y. Transl Psychiatry. 2023. PMID: 37898606 Free PMC article.
-
Plasma fatty acids and attention deficit hyperactivity disorder: a Mendelian randomization investigation.Front Psychiatry. 2024 May 3;15:1368942. doi: 10.3389/fpsyt.2024.1368942. eCollection 2024. Front Psychiatry. 2024. PMID: 38764473 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources